These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9821542)

  • 21. Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental area.
    Mahmoodi G; Ahmadi S; Pourmotabbed A; Oryan S; Zarrindast MR
    Neurobiol Learn Mem; 2010 Jul; 94(1):83-90. PubMed ID: 20403448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity.
    Bertaina-Anglade V; Enjuanes E; Morillon D; Drieu la Rochelle C
    J Pharmacol Toxicol Methods; 2006; 54(2):99-105. PubMed ID: 16750402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of different types of pre-training on the rat's retention performance in a swim-to-platform task following administration of scopolamine.
    Caldji C; Vanderwolf CH
    Behav Brain Res; 1996 Oct; 80(1-2):217-20. PubMed ID: 8905146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scopolamine effects on memory retention in mice: a model of dementia?
    Flood JF; Cherkin A
    Behav Neural Biol; 1986 Mar; 45(2):169-84. PubMed ID: 3964171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat.
    Yamaguchi Y; Kobayashi H
    Neuropeptides; 1994 Mar; 26(3):153-8. PubMed ID: 8208360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interactive effects of nicotinic and muscarinic cholinergic receptor inhibition on fear conditioning in young and aged C57BL/6 mice.
    Feiro O; Gould TJ
    Pharmacol Biochem Behav; 2005 Feb; 80(2):251-62. PubMed ID: 15680178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose attenuates the effect of combined muscarinic-nicotinic receptor blockade on spontaneous alternation.
    Ragozzino ME; Arankowsky-Sandoval G; Gold PE
    Eur J Pharmacol; 1994 Apr; 256(1):31-6. PubMed ID: 8026561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memory modulation with peripherally acting cholinergic drugs.
    Rush DK; Streit K
    Psychopharmacology (Berl); 1992; 106(3):375-82. PubMed ID: 1570386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 5-HT
    Aparicio-Nava L; Márquez-García LA; Meneses A
    Behav Brain Res; 2019 Jan; 357-358():98-103. PubMed ID: 29330003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of amphetamine on the plus-maze discriminative avoidance task in mice.
    Silva RH; Kameda SR; Carvalho RC; Rigo GS; Costa KL; Taricano ID; Frussa-Filho R
    Psychopharmacology (Berl); 2002 Feb; 160(1):9-18. PubMed ID: 11862369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine genetic variance in muscarinic cholinergic receptor antagonism of acquisition and expression of sucrose-conditioned flavor preferences in three inbred mouse strains.
    Iskhakov B; Bourie F; Shenouda M; Fazilov G; Buras A; Bhattacharjee D; Dohnalova P; Iskhakova J; Bodnar RJ
    Pharmacol Biochem Behav; 2018 Sep; 172():1-8. PubMed ID: 29969600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bovine brain phosphatidylserine attenuates scopolamine-induced amnesia.
    Claro FT; Silva RH; Frussa-Filho R
    Physiol Behav; 1999 Oct; 67(4):551-4. PubMed ID: 10549892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone potentiates scopolamine-induced disruptions of nonspatial learning in gonadectomized male rats.
    Leonard ST; Moerschbaecher JM; Winsauer PJ
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):48-57. PubMed ID: 17295584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholinergic agents and delay-dependent performance in the rat.
    Buxton A; Callan OA; Blatt EJ; Wong EH; Fontana DJ
    Pharmacol Biochem Behav; 1994 Dec; 49(4):1067-73. PubMed ID: 7886077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of retrieval enhancement by amphetamine following scopolamine-induced amnesia.
    Quartermain D; Jung H
    Pharmacol Biochem Behav; 1989 May; 33(1):51-4. PubMed ID: 2780787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood glucose and brain function: interactions with CNS cholinergic systems.
    Stone WS; Cottrill KL; Walker DL; Gold PE
    Behav Neural Biol; 1988 Nov; 50(3):325-34. PubMed ID: 3202815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen improves working but not reference memory and prevents amnestic effects of scopolamine of a radial-arm maze.
    Fader AJ; Johnson PE; Dohanich GP
    Pharmacol Biochem Behav; 1999 Apr; 62(4):711-7. PubMed ID: 10208377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different effects of scopolamine on the retrieval of spatial memory and fear memory.
    Huang ZB; Wang H; Rao XR; Zhong GF; Hu WH; Sheng GQ
    Behav Brain Res; 2011 Aug; 221(2):604-9. PubMed ID: 20553767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats.
    Ballard TM; McAllister KH
    Psychopharmacology (Berl); 1999 Sep; 146(1):10-8. PubMed ID: 10485959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMDA antagonists potentiate scopolamine-induced amnesic effect.
    Li HB; Matsumoto K; Tohda M; Yamamoto M; Watanabe H
    Behav Brain Res; 1997 Feb; 83(1-2):225-8. PubMed ID: 9062690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.